Clinical Trial Update: Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Baylor Breast Care Center is evaluating simvastatin in combination with dual anti-HER2 therapy for metastatic breast cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• SIMVASTATIN (SIMVASTATIN)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer Stage IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING